New Suitability Petitions - March 2026
Please find attached the report on list of drugs with
Suitability Petitions activities for the month of March 2026 (filed / accepted
/ rejected / approved). The current month report covers the below products:
- Gabapentin
- Estradiol
- Buspirone Hydrochloride
- Progesterone
- Levetiracetam
- Ibuprofen
- Pregabalin
- Atomoxetine
Hydrochloride
- Sildenafil
- Estrogens, Conjugated
- Hydrocortisone
- Clomiphene Citrate
- Acetaminophen; Oxycodone
Hydrochloride
- Metformin Hydrochloride
- Methimazole
- Diclofenac Sodium
- Methylphenidate
Hydrochloride
- Liothyronine Sodium
- Tizanidine
- Acetaminophen; Oxycodone
Hydrochloride
- Dapsone
- Gabapentin
- Oxybutynin Chloride
- Tramadol Hydrochloride